About Us
In 2025, we stand on the edge of a breakthrough and we need your help to take the next leap.
Who are we?
Brain 4 Life is a registered non-profit dedicated to improving access to specialised health services to support individuals affected by sports-related concussions and brain trauma, increasing community education and awareness of CTE, and implementing science-backed preventative measures for individuals at risk of sports-related brain trauma.
What is CTE?
Chronic Traumatic Encephalopathy, or CTE, is a progressive and degenerative brain disease that is associated with repeated head injuries such as concussions or subconcussions. CTE affects how areas of the brain function and communicate. This disruption of normal brain functioning can activate a range of cognitive, emotional and behavioural issues. Currently, the only way to definitively diagnose CTE is through post-mortem neuropathological autopsy.
Our Promise
Real Outcomes for Real People
CTE intersects with broader conditions like Alzheimer’s, Parkinson’s, and motor neurone disease. Behind each Individual is a family, a community, and a future affected.
Your support fuels hope for individuals and families affected by brain disease today, and for generations to come. Together, we can drive groundbreaking research, advance early diagnosis, and bring life-changing treatments within reach.
At Brain 4 Life Ltd, we believe in a future where the devastating impact of brain diseases like Chronic Traumatic Encephalopathy (CTE) can be reversed—where diagnosis during life and targeted treatments are not only possible, but within reach.
We are proud to support and partner with the Australian Sports Brain Bank (ASBB)—Australia’s foremost research initiative tackling sports-related brain injury. Since 2018, the ASBB has made historic progress in understanding and diagnosing CTE, and with our backing, they have published a record 18 peer-reviewed articles—more than any other team in Australasia.
Through ground-breaking research led by the ASBB and supported by Brain 4 Life, scientists have identified a 21-gene molecular signature unique to CTE-affected brain tissue.
This discovery could enable:
01
The first-ever diagnostic test for CTE in living individuals.
02
The development of reliable biomarkers for early detection.
03
Targeted therapies that may slow, halt, or even reverse the disease.